- Home
- MRNA vs NIO Comparison
MRNA vs NIO Comparison
Compare MRNA & NIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- NIO
- Stock Information
- Founded
- MRNA 2010
- NIO 2014
- Country
- MRNA United States
- NIO China
- Employees
- MRNA N/A
- NIO N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- NIO Auto Manufacturing
- Sector
- MRNA Health Care
- NIO Consumer Discretionary
- Exchange
- MRNA Nasdaq
- NIO Nasdaq
- Market Cap
- MRNA 9.2B
- NIO 16.9B
- IPO Year
- MRNA 2018
- NIO 2018
- Fundamental
- Price
- MRNA $27.08
- NIO $6.52
- Analyst Decision
- MRNA Hold
- NIO Buy
- Analyst Count
- MRNA 15
- NIO 9
- Target Price
- MRNA $36.69
- NIO $6.63
- AVG Volume (30 Days)
- MRNA 12.1M
- NIO 51.7M
- Earning Date
- MRNA 11-06-2025
- NIO 11-25-2025
- Dividend Yield
- MRNA N/A
- NIO N/A
- EPS Growth
- MRNA N/A
- NIO N/A
- EPS
- MRNA N/A
- NIO N/A
- Revenue
- MRNA $2,232,000,000.00
- NIO $9,690,436,500.00
- Revenue This Year
- MRNA N/A
- NIO $37.34
- Revenue Next Year
- MRNA $10.38
- NIO $45.60
- P/E Ratio
- MRNA N/A
- NIO N/A
- Revenue Growth
- MRNA N/A
- NIO 9.28
- 52 Week Low
- MRNA $23.04
- NIO $3.02
- 52 Week High
- MRNA $48.92
- NIO $8.02
- Technical
- Relative Strength Index (RSI)
- MRNA 55.06
- NIO 40.45
- Support Level
- MRNA $23.04
- NIO $7.07
- Resistance Level
- MRNA $25.56
- NIO $7.06
- Average True Range (ATR)
- MRNA 1.58
- NIO 0.30
- MACD
- MRNA 0.07
- NIO -0.08
- Stochastic Oscillator
- MRNA 65.26
- NIO 15.83
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About NIO NIO Inc. American depositary shares each representing one ordinary share
Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 222,000 EVs in 2024, accounting for about 2% of the China passenger new energy vehicle market.